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Osteoinductive activity of demineralized bone matrix and
deprotenized  bone derived from human avascular ne-
crotic femoral head
ZHANG Bo 张波, LIU Ming-yong 刘明勇 and ZHAO Jian-hua赵建华*
Objective:    To observe the osteoinductive activity of
demineralized bone matrix (DBM) and deprotenized  bone
(DPB) made from human avascular necrotic femoral head.
Methods:    The femoral head was cut into pieces with the
size of 3 mm×3 mm×5 mm, which were made into DBM and
DPB. These two kinds of biomaterials were cocultured with
human bone mesenchymal stem cells (hBMSCs). Monolayer
cells without biomaterials were cultured as control.  Prolifera-
tive activity of hBMSCs was evaluated on days 1, 3, 5, 7 and 14.
The concentration of alkaline phosphatase (ALP), osteocalcin
(OC), and Ca2+  were detected on days 1, 7, 14 and  21.
Results:    Cells cultured in DBM showed higher prolif-
erative activity than did in DPB and monolayer cells (F=
39.773, P<0.01). DBM and DPB also had osteoinductive
activity. The concentrations of  ALP (F=93.162, P<0.01),
OC (F=236.852,  P<0.01), Ca2+ (F=80.711, P<0.01) of  DBM group
were significantly higher than that of DPB and control groups.
Conclusions:    In vitro, DBM and DPB made from avas-
cular necrotic femoral head have osteoinductive activity
when cocultured with hBMSCs, and  the former is stronger
than the latter.
Key words:     Femur head; Bone matrix; Mesenchy-
mal stem cells; Bone substitutes
There are many patients who have bone defectdue to tumor, trauma, infection or other reasons.It is difficult to reconstruct the bone defect un-
less transplanting bone biomaterials. At present, there
are several kinds of bone biomaterials that are widely
used. These biomaterials could be categorized as au-
tologous bone, allograft bone, xenogenic bone and syn-
thetic materials. The best bone biomaterial is autolo-
gous bone,1 as autologous bone has excellent combi-
nation of  osteoconduction, osteoinduction and
osteogenesis, which is essential for bone repair.
However, autologous bone is quite limited in amount,
size and shape; moreover, there are some complica-
tions in donors, such as infection and hemorraghe.2
Xenogenic bone can be easily harvested from animals,
but its use is limited because of its severe immunologi-
cal rejection. Allograft bone is another kind of biomaterial.
The material is prepared from donated human bone.
In recent years, total hip replacement has widely
been conducted. As a result the amount of bone mass
left from femoral head resection is large, which is a
potential source of allograft bone. However, whether
avascular necrotic femoral head, which is a major rea-
son leading to total hip replacement, has the same prop-
erties of osteoinduction and osteoconduction as nor-
mal bone has, is the decisive factor for this potential
source. To investigate this issue, we prepared two kinds
of allograft bone biomaterials from avascular necrotic
femoral heads: demineralized bone matrix (DBM) and
deproteinized bone (DPB), which are widely used in
clinic. We observed some physical characteristics of
the biomaterials and  their osteoinductive activity to
human bone marrow mesenchymal stem cells
(hBMSCs).
METHODS
Materials
DMEM-LG (Dulbecco’s modified Eagles medium
with low glucose, Hyclone, USA), Best fetal calf serum
(TBD, Tianjin, China), MTT powder (3, 4, 5-
dimethylthiazol-zyl, 5-diphenyltetrazdium bromide,
Ameresco, USA), 1.077 g/ml human lymphocyte iso-
lation medium (TBD, Tianjin, China), Rabbit-anti human
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CD105, CD44 (Bosde, Wuhan, China), ALP test kit
(Jianchen, Nanjing, China), Human osteocalcin quanti-
tative test kit (RD, USA).
Preparation of DBM and DPB
Avascular necrotic femoral heads were collected
after hip replacement. Inclusion criteria are: (1) avascu-
lar necorsis of femoral head at Ficat stage III or IV, and
(2) no infection, hepatitis, tumors or sexually transmit-
ted diseases. The fibrous connective tissue, bone mar-
row and cartilage plaque were cleared off. These mate-
rials were cut into 3 mm×3 mm×5 mm bone particles.
DBM was prepared according to Maddox’s method,3
and DPB prepared according to modified Kiel’s method,4
The appearance was observed and the pore diameter
was measured under scanning electron microscope
(SEM). Biomaterials were sterilized by 60Co-ray
radiation, preserved at 4°C ice-box.
Isolation, cultivation and identification of hBMSCs
After informed consent, human bone marrow was
obtained from iliac crest of healthy volunteers, and then
centrifuged with human lymphocyte isolation medium,
3000 r/min for 20 minutes. The donors’ ages were 35-
50 years. The cell pellet was collected and rinsed in D-
Hank’s medium, and then centrifuged at 1500 r/min for
10 minutes. The supernatant was removed and DMEM-
LG supplemented with 15% fetal calf serum (FCS), 100
U/ml of penicillin, 100 µg/ml streptomycin was addad.
The exact cell number was determined in a counting
chamber. The well prepared cell suspension was in-
oculated into 25 cm2 culture flasks with the concentra-
tion of 1-2×105/cm2. Standard incubation conditions
were used (37°C, 95% air, 5%CO2). Media were changed
after 24 hours, and then changed every 3-4 days.
BMSCs were passaged when the cells were nearly
confluent. Immunohistochemical staining of the pas-
sage 3 hBMSCs was performed by the avidin-biotin com-
plex (ABC) method using monoclonal antibodies against
CD44 and CD105, and coloration by diaminobenzidine
(DAB).
Three dimensional culture
These two kinds of biomaterials were soaked in PBS
and DMEM-LG prior to cell seeding, and then preserved
in 4°C ice-box. DBM and DPB (3 mm×3 mm×5 mm)
particles were seeded with 1×106 cells. The seeded
matrices were kept in culture using serial subcultivation
solution. Additionally, 1×10-8 mol/L dexamethasone, 50
µg/ml ascorbic acid and 10 mmol β-glycerophosphates
were added. BMSCs in monolayer culture (1×106) on tis-
sue culture plate were kept in the same media as controls.
Biochemical evaluation
Cell proliferation activity was evaluated on days 1,
3, 5, 7, 14. Samples in every group were reacted with 5
mg/ml MTT for 4 hours, added 150 µl dimethyl sulfox-
ide (DMSO), vortexed for 10 minutes, drew off 100 µl
solution, measured at 490 nm.
On days 1, 7, 14, 21, alkaline phosphatase activity
was assessed. All matrices were harvested,  smashed,
trypsinized. Cells on matrices were broken into pieces
by ultrasound and centrifuged for 5 minutes at 2000 r/
min. The content of ALP was assessed according to
the introduction of the test kit. The coloring reaction
was measured at 405 nm. Osteocalcin content was
quantified using human osteocalcin ELISA kit. Ca2+ con-
centration of every group was measured using Vitros
automatic biochemical analyzer.
Statistic analysis
Significant differences among groups were identi-
fied by a one-way analysis of variance (ANOVA) with
SPSS 13.0. P<0.05 was considered statistically sig-
nificant difference.
RESULTS
Physical characteristics of biomaterials
DBM was yellowish in color and soft in texture, while
DPB was pure white, hard and fragile. The pore surface of
DBM was rough and the pore diameter was 15.4-88.4 µm
(mean 40.85 µm±21.75 µm, Fig .1). The pore surface of
DPB was smooth and the pore diameter was 127-530
µm (mean 285.14 µm±124.43 µm, Fig. 2).
Observation and identification of BMSCs
hBMSCs isolated from bone marrow were spherical
in shape. Cell adherence could be seen after 24-hour
cultivation. Spindle cells were found on day 5. Primary
cells reached 80% of confluence after 12 days’ cultiva-
tion and 100% of confluence at about 17 days. Pas-
saged cells reached 80% of confluence after 5-7 days’
cultivation. Cells were slender and had some overshoots.
They arranged like whirlpool.  After immunohistochemi-
cal staining, the cytomembrane of hBMSCs became
brown (Fig .3).
Chinese Journal of Traumatology 2009; 12(6):379-383 . 381 .
Cell proliferation activity
  Cells showed proliferation activity on both kinds of
biomaterials, so did cells in control group. With the
passage time passing by, more cells proliferated. The
cell multiplication appeared on day 3. DBM group
showed significant difference with DPB group and con-
trol group on days 3, 5, 7, 14 (P<0.01), while DPB group
had no significant difference with control group (P>0.05).
ALP content
In DBM and DPB group, the content of ALP was
much higher with the passage of time prolonged. DBM
group maintained a high level on days 7,14 and 21. The
control group began to increase on day 7, and decreased
on days 14 and 21. On days 7, 14, 21,  DBM group
showed significant difference with DPB group and con-
trol group (P<0.05), while DPB group also had signifi-
cant difference with control group (P<0.05, Fig. 5).
OC content
OC content increased with time passing by in all
groups. DBM group showed more obvious increase on
days 7, 14, 21 and there was significant difference in
comparison with DPB and control groups (P<0.01).
There was no significant difference between DPB group
and control one (P>0.05, Fig. 6).
Ca2+ concentration
 Ca2+ concentration of all groups decreased
gradually, especially in DBM group. On days 7, 14, 21,
DBM group had significant difference with DPB and
control groups (P<0.05), and DPB group had no signifi-
cant difference with control group (P>0.05, Fig. 7).
Fig. 1.  DBM was rough and the pore diameter was 15.4-88.4 µm, with average pore diameter of 40.85 µm±21.75 µm (SEM×200). Fig. 2.
The pore surface of DPB was smooth and the pore diameter was 127-530 µm, with average pore diameter of 285.14 µm±124.43 µm.
(SEM×35). Fig. 3.  hBMSCs surface antigen CD44 (A), CD105 (B), there were many brown particles on the membrane (ABC×200).
DISCUSSION
DBM and DPB are two kinds of widely used
biomaterials in clinic. DBM contains many matrix
proteins, such as collagen, bone morphogenetic pro-
tein (BMP), which have significantly  osteoinductive and
osteoconductive activity.5 However, studies have shown
that DBM could induce host immune responses be-
cause of its matrix proteins.6  DPB  keeps natural 3D
structure and porosity of bone tissue. It also has strong
osteoconductive properties and low immunogenicity.7
Some growth factors and bone matrix proteins may
physically infiltrate into DPB by passing through the
porous architecture or bind directly to the hydroxyapa-
tite crystals, which can help BMSCs migrate, attach
and ossify.8 DPB also has lower osteoinductive activity
because of absence of organic materials. So we made
femoral head into half DPB by modified Kiel’s method,
expecting by this way would enhance the mechanical
properties and osteoinductive activity of DPB.
BMSCs that have differential potentiality exist in the
endosteum and perivascualr cells. They have been dis-
covered by Friedenstein in 1968.9 They can differenti-
ate into osteocytes, chondrocyte, adipocyte, and fibroblast.10
They also can differentiate into cadiocyte,11,12 renal cells,13
Fig. 4.  Cell proliferation in all groups. Fig. 5.  There was significant difference in ALP between groups. Fig. 6. OC concentration in each
group. Fig. 7.  Ca2+ concentration in each group.
                                      Fig.4                                                                         Fig.5                                                                            Fig.6                                                     
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lung parenchyma cells,14 and neurocytes15.16 under con-
trol led conditions. Because of  their powerful
selfreplication and multi-differentiation, they are widely
used in tissue reparation, especially in bone tissue
engineering. Experiments showed that biomaterials
have formed much more bone with BMSCs than they
are only in vivo.17 BMSCs combined with biomaterials
can diminish the recipient cell migration and expansion
to defect site and speed osseointegration.18.19 BMSCs also
have low immunogenicity.20 So, it is more useful to study
the osteoinductive activity of biomaterials when
cocultured with BMSCs in vitro.
According to the result of MTT, DBM group had sig-
nificant difference with DPB and control groups on days
3, 5, 7, 14, while DPB group had no significant differ-
ence with control group. The results indicate that DBM
made from avascular necrotic femoral head contains
bioactive materials which are available to cell attach
and proliferate.
ALP is critical during the course of bone tissue
mineralization. The content of ALP is related to the num-
ber of osteoblast.21 The ALP content of DBM and DPB
groups has significant difference with control group
(monolayer cells), which indicates that monolayer
hBMSC has lower differentiation efficiency. According
to the results of ALP test, we can conclude that DBM
and DPB made from avascular femoral head contain
bioactive materials, which could promote hBMSC to
differentiate into osteoblast, especially DBM.
OC, similar to ALP, is also a marker of hBMSCs
differentiation into osteoblasts.22 OC content of all groups
increased with time passing by. DBM made from avas-
cular femoral head performed higher osteoinductivity,
while DPB made from avascular femoral head performed
lower osteoinductivity. Ca2+ is involved in the bone
formation. Ca2+ content of the matrix can reflect the
ability of hBMSCs differentiation indirectly. After the test
of Ca2+, we draw the same results as the test of OC.
DBM and DPB, made from avascular necrotic femo-
ral head, have osteoinductive activity. DBM group has
significant difference with DPB and control groups in
cell proliferation or osteoinductive activity. DBM group
has more powerful osteoinductive activity than DPB
group. Although half DPB was used in this experiment,
it performed lower osteoinductive activity. The reasons
we consider are: (1) The content of organic matter is
lower in avascular necrotic femoral head than normal
one, and it would be much lower after deproteinization.
(2) The pores of avascular necrotic femoral head have
enlarged because of osteoporosis and deproteinization,
which affects cell attachment, proliferation and
ossification. (3) The inside structure of DPB made from
avascular necrotic femoral head is not stable. After
deproteinization and frozen drying, it become more
fragile, which will influence cell attachment and
osteoinductive activity.
    In general, human avascular necrotic femoral head
could be a source of xenogenic bone biomaterials, and
DBM made from it has satisfactory osteoinductive
activ ity. There are some shortages about the
biomaterials. DPB has large pores and fragile inside
structure. Many researchers have engaged in improv-
ing the osteoinductive activity of biomaterials. Park23
combined synthetic oligopeptide with DPB and trans-
planted them into teeth socket of adult beagle dogs.
They found this compound had formed more new bone
than DPB alone. Hang24 crosslinked heparin with DBM.
This linkage enforced the DBM combination with BMP-
2 and also increased its compression modulus by 7
times, which improved the osteogeneic activity and
mechanical nature of DBM significantly. The technol-
ogy of preparation should be changed or improved. The
structure of avascular necrotic femoral head is different
from normal osintegumentale and cancellous bone. It
probably would destroy the inside structure of the bone
using the current reagent and concentration. Therefore
future effort should target towards studying the prepa-
ration technology suitable for avascular necrotic femo-
ral head.
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